| Year |
Citation |
Score |
| 2022 |
Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, Chan WN, Chan AKY, Cheung AHK, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, et al. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways. The Journal of Pathology. PMID 36373776 DOI: 10.1002/path.6033 |
0.321 |
|
| 2021 |
Kang W, Zhang J, Huang T, Zhou Y, Wong CC, Chan RCK, Dong Y, Wu F, Zhang B, Wu WKK, Chan MWY, Cheng ASL, Yu J, Wong N, Lo KW, et al. NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway. Oncogene. PMID 33452458 DOI: 10.1038/s41388-020-01579-3 |
0.393 |
|
| 2019 |
Li T, Li B, Sara A, Ay C, Leung WY, Zhang Y, Dong Y, Liang Q, Zhang X, Weidner P, Gutting T, Behrens HM, Röcken C, Sung JJ, Ebert MP, et al. Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer. Oncoimmunology. 8: e1649961. PMID 31646096 DOI: 10.1080/2162402X.2019.1649961 |
0.374 |
|
| 2019 |
Dong Y, Zhang Y, Kang W, Wang G, Chen H, Higashimori A, Nakatsu G, Go M, Tong JH, Zheng S, To KF, Sung JJ, Yang X, Ng SS, Yu J. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6. Theranostics. 9: 6517-6531. PMID 31588233 DOI: 10.7150/Thno.34989 |
0.409 |
|
| 2019 |
Wang X, Liang JQ, Zhang LH, Gou H, Li Z, Chen H, Dong Y, Ji J, Yu J. C8orf76 promotes gastric tumorigenicity and metastasis by directly inducing lncRNA DUSP5P1 and associates with patient outcomes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30733230 DOI: 10.1158/1078-0432.Ccr-18-2804 |
0.359 |
|
| 2018 |
Zhang J, Zhou Y, Huang T, Wu F, Pan Y, Dong Y, Wang Y, Chan AKY, Liu L, Kwan JSH, Cheung AHK, Wong CC, Lo AKF, Cheng ASL, Yu J, et al. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p. Oncogene. PMID 30082912 DOI: 10.1038/S41388-018-0430-X |
0.435 |
|
| 2018 |
Cheung AH, Chow C, Zhang J, Zhou Y, Huang T, Ng KC, Or TC, Yao YY, Dong Y, Fung JM, Xiong L, Chan AK, Lung WR, Kang W, To KF. Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 29748615 DOI: 10.1038/S41374-018-0056-1 |
0.322 |
|
| 2018 |
Zhang Y, Wang S, Kang W, Liu C, Dong Y, Ren F, Wang Y, Zhang J, Wang G, To KF, Zhang X, Sung JJ, Chang Z, Yu J. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation. Oncogene. PMID 29563608 DOI: 10.1038/S41388-018-0161-Z |
0.385 |
|
| 2018 |
Liu L, Zhang Y, Wong CC, Zhang J, Dong Y, Li X, Kang W, Chan FK, Sung JJ, Yu J. RNF6 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of TLE3. Cancer Research. PMID 29374067 DOI: 10.1158/0008-5472.Can-17-2683 |
0.407 |
|
| 2018 |
Higashimori A, Dong Y, Zhang Y, Kang W, Nakatsu G, Ng SS, Arakawa T, Sung JJ, Chan FK, Yu J. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-β-catenin signaling axis. Cancer Research. PMID 29374064 DOI: 10.1158/0008-5472.Can-17-2403 |
0.397 |
|
| 2018 |
Kang W, Huang T, Zhou Y, Zhang J, Lung RWM, Tong JHM, Chan AWH, Zhang B, Wong CC, Wu F, Dong Y, Wang S, Yang W, Pan Y, Chak WP, et al. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. Cell Death & Disease. 9: 92. PMID 29367737 DOI: 10.1038/S41419-017-0134-0 |
0.447 |
|
| 2018 |
Ng SS, Dong Y, Leung WW, Ma BB, To KF, Sung JJ, Yu J. 374 - MIR-133A is a Predictive Biomarker in Patients with Metastatic Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)30742-X |
0.427 |
|
| 2017 |
Huang T, Zhou Y, Zhang J, Wong CC, Li W, Kwan JSH, Yang R, Chan AKY, Dong Y, Wu F, Zhang B, Cheung AHK, Wu WKK, Cheng ASL, Yu J, et al. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis. Oncogene. PMID 29234151 DOI: 10.1038/S41388-017-0029-7 |
0.478 |
|
| 2017 |
Zhou Y, Huang T, Zhang J, Wong CC, Zhang B, Dong Y, Wu F, Tong JHM, Wu WKK, Cheng ASL, Yu J, Kang W, To KF. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. PMID 28759040 DOI: 10.1038/Onc.2017.257 |
0.458 |
|
| 2017 |
Yang S, Liu Y, Li MY, Ng CSH, Yang SL, Wang S, Zou C, Dong Y, Du J, Long X, Liu LZ, Wan IYP, Mok T, Underwood MJ, Chen GG. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Molecular Cancer. 16: 124. PMID 28716029 DOI: 10.1186/S12943-017-0700-1 |
0.386 |
|
| 2017 |
Tsoi H, Lam KC, Dong Y, Zhang X, Lee CK, Zhang J, Ng SC, Ng SSM, Zheng S, Chen Y, Fang J, Yu J. Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients. Oncogene. PMID 28692053 DOI: 10.1038/Onc.2017.86 |
0.412 |
|
| 2017 |
Zhou Y, Huang T, Siu HL, Wong CC, Dong Y, Wu F, Zhang B, Wu WK, Cheng AS, Yu J, To KF, Kang W. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. Molecular Cancer. 16: 77. PMID 28399871 DOI: 10.1186/S12943-017-0647-2 |
0.458 |
|
| 2016 |
Huang T, Kang W, Zhang B, Wu F, Dong Y, Tong JH, Yang W, Zhou Y, Zhang L, Cheng AS, Yu J, To KF. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis. Molecular Cancer. 15: 9. PMID 26801246 DOI: 10.1186/S12943-016-0493-7 |
0.43 |
|
| 2015 |
Yau TO, Wu CW, Tang CM, Chen Y, Fang J, Dong Y, Liang Q, Ng SS, Chan FK, Sung JJ, Yu J. microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget. PMID 26621842 DOI: 10.18632/Oncotarget.6403 |
0.437 |
|
| 2015 |
Nakatsu G, Li X, Zhou H, Sheng J, Wong SH, Wu WK, Ng SC, Tsoi H, Dong Y, Zhang N, He Y, Kang Q, Cao L, Wang K, Zhang J, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nature Communications. 6: 8727. PMID 26515465 DOI: 10.1038/Ncomms9727 |
0.33 |
|
| 2015 |
Kang W, Tong JH, Lung RW, Dong Y, Zhao J, Liang Q, Zhang L, Pan Y, Yang W, Pang JC, Cheng AS, Yu J, To KF. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma. Molecular Cancer. 14: 52. PMID 25743273 DOI: 10.1186/S12943-015-0323-3 |
0.413 |
|
| 2015 |
Ren A, Dong Y, Tsoi H, Yu J. Detection of miRNA as non-invasive biomarkers of colorectal cancer. International Journal of Molecular Sciences. 16: 2810-23. PMID 25633103 DOI: 10.3390/Ijms16022810 |
0.407 |
|
| 2015 |
Wang S, Dong Y, Zhang Y, Wang X, Xu L, Yang S, Li X, Dong H, Su L, Ng SSM, Chang Z, Sung JJ, Zhang X, Yu J. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer Oncogene. 34: 2575-2585. PMID 25023701 DOI: 10.1038/Onc.2014.201 |
0.393 |
|
| 2014 |
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li Y, Li Z, Ng SS, Sung JJ, Shen L, Yu J. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Oncogene. PMID 25362853 DOI: 10.1038/Onc.2014.348 |
0.42 |
|
| 2014 |
Dong Y, Yu J, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Management and Research. 6: 405-22. PMID 25342918 DOI: 10.2147/Cmar.S35164 |
0.446 |
|
| 2014 |
Kang W, Tong JH, Lung RW, Dong Y, Yang W, Pan Y, Lau KM, Yu J, Cheng AS, To KF. let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. Journal of Translational Medicine. 12: 281. PMID 25288334 DOI: 10.1186/S12967-014-0281-3 |
0.368 |
|
| 2014 |
Yau TO, Wu CW, Dong Y, Tang CM, Ng SS, Chan FK, Sung JJ, Yu J. microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma. British Journal of Cancer. 111: 1765-71. PMID 25233396 DOI: 10.1038/Bjc.2014.484 |
0.413 |
|
| 2014 |
Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, Go MY, Ng EK, Arakawa T, Chan FK, Sung JJ, Yu J. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. The Journal of Pathology. 234: 302-15. PMID 24931004 DOI: 10.1002/Path.4391 |
0.444 |
|
| 2014 |
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu CW, Wang K, Zheng S, Ng SS, Chan FK, Sung JJ, Yu J. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Molecular Cancer. 13: 124. PMID 24885920 DOI: 10.1186/1476-4598-13-124 |
0.469 |
|
| 2014 |
Kang W, Tong JH, Chan AW, Zhao J, Wang S, Dong Y, Sin FM, Yeung S, Cheng AS, Yu J, To K. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma. Oncology Reports. 31: 2579-86. PMID 24756820 DOI: 10.3892/Or.2014.3148 |
0.417 |
|
| 2014 |
Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung WW, Law WT, Yau TO, Chan FK, Sung JJ, Yu J. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2994-3002. PMID 24691020 DOI: 10.1158/1078-0432.Ccr-13-1750 |
0.391 |
|
| 2014 |
Kang W, Tong JH, Chan AW, Zhao J, Dong Y, Wang S, Yang W, Sin FM, Ng SS, Yu J, Cheng AS, To KF. Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma. Journal of Translational Medicine. 12: 80. PMID 24674326 DOI: 10.1186/1479-5876-12-80 |
0.433 |
|
| 2013 |
Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, Ng SS, Yu J. Tumor suppressor functions of miR-133a in colorectal cancer. Molecular Cancer Research : McR. 11: 1051-60. PMID 23723074 DOI: 10.1158/1541-7786.Mcr-13-0061 |
0.454 |
|
| 2013 |
Zhao J, Liang Q, Cheung KF, Kang W, Dong Y, Lung RW, Tong JH, To KF, Sung JJ, Yu J. Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. British Journal of Cancer. 108: 2557-64. PMID 23722468 DOI: 10.1038/Bjc.2013.263 |
0.366 |
|
| 2013 |
Wu CW, Dong YJ, Liang QY, He XQ, Ng SS, Chan FK, Sung JJ, Yu J. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. Plos One. 8: e57036. PMID 23437304 DOI: 10.1371/Journal.Pone.0057036 |
0.415 |
|
| 2013 |
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene. 32: 5078-88. PMID 23208495 DOI: 10.1038/Onc.2012.526 |
0.493 |
|
| 2013 |
Zhang L, Dong YJ, Zhu N, Wu C, Zhao J, Sung JJY, Ng S, Yu J. Sa1706 MicroRNA-139-5p Exerts Tumor Suppressor Function by Targeting Notch1 and Jun in Colorectal Cancer Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)61019-7 |
0.319 |
|
| 2012 |
He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Molecular Medicine (Cambridge, Mass.). 18: 1491-8. PMID 23255074 DOI: 10.2119/Molmed.2012.00304 |
0.464 |
|
| 2012 |
Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, Chan FK, Yu J, Sung JJ. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut. 61: 739-45. PMID 21930727 DOI: 10.1136/Gut.2011.239236 |
0.329 |
|
| 2012 |
Dong YJ, Wu C, He XQ, Zhang N, Sung JJ, Ng S, Yu J. 1051 MiR-133a Inhibits Colorectal Cancer Cell Growth by Direct Targeting E3 Ubiquitin Ligase RFFL and Activating p53-p21CIP1/WAF1 Pathway Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)60694-5 |
0.346 |
|
| 2011 |
Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS. MicroRNA dysregulation in colorectal cancer: a clinical perspective. British Journal of Cancer. 104: 893-8. PMID 21364594 DOI: 10.1038/Bjc.2011.57 |
0.36 |
|
| Show low-probability matches. |